Gigamon, CBL & Associates Properties and Cytokinetics Set to Join S&P SmallCap 600

NEW YORK, April 17, 2017 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600 indices:

• Gigamon Inc. (NYSE: GIMO) will replace Ixia (NASD: XXIA) effective prior to the open on Thursday, April 20. S&P MidCap 400 constituent Keysight Technologies Inc. (NYSE: KEYS) is acquiring Ixia in a deal expected to be completed on or about that date pending final conditions.

• CBL & Associates Properties Inc. (NYSE: CBL) will replace Air Methods Corp. (NASD: AIRM) effective prior to the open on Monday, April 24. American Securities LLC is acquiring Air Methods in a deal expected to be completed soon pending final conditions.

• Cytokinetics Inc. (NASD: CYTK) will replace Cardinal Financial Corp. (NASD: CFNL) effective prior to the open on Monday, April 24. S&P MidCap 400 constituent United Bankshares Inc. (NASD: UBSI) is acquiring Cardinal Financial in a deal expected to be completed on or about that date pending final conditions.

Gigamon develops and delivers solutions that deliver visibility and control of data-in-motion traversing enterprise, federal, and service provider networks. Headquartered in Santa Clara, CA, the company will be added to the S&P SmallCap 600 GICS (Global Industry Classification Standard) Systems Software Sub-Industry index.

CBL & Associates Properties, a public real estate investment trust (REIT), owns, develops, manages and operates regional shopping malls, open-air and mixed-use centers, outlet centers, associated centers, community centers and office properties. Headquartered in Chattanooga, TN, the company will be added to the S&P SmallCap 600 GICS Retail REITS Sub-Industry index.

Cytokinetics is a late-stage biopharmaceutical company, focusing on discovering, developing, and commercializing muscle activators. Headquartered in South San Francisco, CA, the company will be added to the S&P SmallCap 600 GICS Biotechnology Sub-Industry index.

Following is a summary of the changes:

For more information about S&P Dow Jones Indices, please visit www.spdji.com.

ABOUT S&P DOW JONES INDICES

S&P Dow Jones Indices is the largest global resource for essential index-based concepts, data and research, and home to iconic financial market indicators, such as the S&P 500^® and the Dow Jones Industrial Average^®. More assets are invested in products based on our indices than based on any other provider in the world. With over 1,000,000 indices and more than 120 years of experience constructing innovative and transparent solutions, S&P Dow Jones Indices defines the way investors measure and trade the markets.

S&P Dow Jones Indices is a division of S&P Global (NYSE: SPGI), which provides essential intelligence for individuals, companies, and governments to make decisions with confidence. For more information, visit www.spdji.com.

FOR MORE INFORMATION:

Soogyung Jordan
Global Head of Communications 
New York, USA
(+1) 212 438 2297
soogyung.jordan@spglobal.com

David Blitzer
Managing Director and Chairman of the Index Committee 
New York, USA
(+1) 212 438 3907
david.blitzer@spglobal.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/gigamon-cbl--associates-properties-and-cytokinetics-set-to-join-sp-smallcap-600-300440518.html

SOURCE S&P Dow Jones Indices